NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 119 filers reported holding NURIX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $14,621,000 | -44.2% | 1,154,000 | -38.3% | 0.31% | -23.7% |
Q1 2022 | $26,199,000 | -51.6% | 1,870,000 | 0.0% | 0.41% | -40.8% |
Q4 2021 | $54,137,000 | +50.6% | 1,870,000 | +55.8% | 0.69% | +46.0% |
Q3 2021 | $35,952,000 | +12.9% | 1,200,000 | 0.0% | 0.47% | +10.7% |
Q2 2021 | $31,836,000 | -14.7% | 1,200,000 | 0.0% | 0.43% | -22.6% |
Q1 2021 | $37,308,000 | +8.1% | 1,200,000 | +14.3% | 0.55% | +4.5% |
Q4 2020 | $34,524,000 | +98.7% | 1,050,000 | +111.0% | 0.53% | +55.6% |
Q3 2020 | $17,376,000 | – | 497,740 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,822,883 | $14,327,860 | 1.60% |
DAFNA Capital Management LLC | 556,695 | $4,375,623 | 1.36% |
Redmile Group, LLC | 2,848,827 | $22,391,780 | 1.06% |
Deep Track Capital, LP | 2,997,830 | $23,562,944 | 0.91% |
WestHill Financial Advisors, Inc. | 283,333 | $2,226,997 | 0.65% |
Soleus Capital Management, L.P. | 814,000 | $6,398,040 | 0.59% |
Affinity Asset Advisors, LLC | 250,000 | $1,965,000 | 0.55% |
Boxer Capital, LLC | 1,224,892 | $9,627,651 | 0.51% |
AtonRa Partners | 24,227 | $190,424 | 0.40% |
WASATCH ADVISORS LP | 3,564,616 | $28,017,882 | 0.18% |